What is the generic name?

TILDRAKIZUMAB-ASMN

What is the Trade Name for TILDRAKIZUMAB-ASMN?

ILUMYA

What are the Indications for TILDRAKIZUMAB-ASMN?

• 1 INDICATIONS AND USAGE ILUMYA ¬Æ is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ( 1 )

References: https://open.fda.gov/